You win some, you lose some—and that’s certainly true for Vivos Therapeutics, which reported on Monday the FDA’s clearance of one device to treat obstructive sleep apnea alongside the denial of ...
Vivos Therapeutics, Inc. has announced the publication of positive results from a multicenter clinical trial on its Daytime-Nighttime Appliance (DNA) for treating obstructive sleep apnea (OSA) in ...
Vivo X300 FE and Vivo X200T have cleared BIS certification in India, hinting at an imminent launch. Here’s what we know so ...
In much the same way that they’re designed to expand wearers’ upper airways, Vivos Therapeutics’ slate of oral appliances have now expanded their FDA indications, too. Collectively known as the ...
Vivos Therapeutics stock leaped after the medical-technology provider garnered FDA clearance for a device to treat sleep apnea. Vivos Therapeutics (VVOS) shares on Monday leaped after the ...
LITTLETON, Colo., April 09, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (VVOS), a leading medical device and technology company specializing in the development and commercialization of highly ...
With this unprecedented FDA clearance, Vivos redefines what it means to have a truly non-invasive treatment for all levels of OSA severity, opening new revenue opportunities for Vivos LITTLETON, Colo.
MANILA, PHILIPPINES - 2025 became a milestone year for vivo Philippines, opening a new decade of innovation as the brand ...
Vivos Therapeutics Inc (NASDAQ:VVOS) announced the results of a recent clinical observational study on the application of Vivos' Preventive Oral Device, dubbed POD, for treating and preventing ...
LITTLETON, Colo., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (NASDAQ: VVOS), a leading medical device and healthcare services company specializing in the ...
LITTLETON, Colo., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and healthcare services company specializing in the ...
Financial results highlighted by 78% sequential quarter over quarter revenue growth, showing the impact of the first full quarter of Sleep Center of Nevada operations Management to host conference ...